Guest guest Posted January 31, 2008 Report Share Posted January 31, 2008 From Journal of Viral Hepatitis Therapy Expectations and Physical Comorbidity Affect Quality of Life in Chronic Hepatitis C Virus Infection Posted 01/23/2008 G. Taliani; P. Rucci; E. Biliotti; L. Cirrincione; A. Aghemo; A. Alberti; P. L. Almasio; D. Bartolozzi; N. Caporaso; R. Coppola; M. Chiaramonte; A. Floreani; G. B. Gaeta; M. Persico; G. Secchi; I. Versace; S. Zacharia; A. Mele Abstract and Introduction Abstract Summary. Hepatitis C virus (HCV) infection is associated with a significant reduction of health related quality of life (QOL), the causes and mechanisms of which are still unknown. To explore whether treatment history could affect QOL, we examined patients with detectable HCV viraemia who had a different therapeutic background. Two hundred sixty-four consecutive subjects with chronic HCV infection and detectable viraemia were enrolled. Of these, 163 were untreated patients, 43 were relapsers, 58 were nonresponders (NR) to nonpegylated interferon (IFN) therapy. To assess QOL, three self-report instruments were employed: the Short Form-36 (SF-36), the Chronic Liver Disease Questionnaire (CLDQ-I) and the World Health Organization Quality of Life assessment (WHOQOL-BREF). Clinical and demographic data were collected, and the QOL scores of HCV-positive patients were compared with those of an Italian normative sample and healthy controls. Further antiviral treatment was offered to untreated and relapsed patients but not to NR. All patient groups displayed lower QOL scores compared with the normative sample and controls. NR displayed lower QOL scores in several areas compared with untreated patients and relapsers. In multivariate regression analyses, being NR and having a physical comorbidity were significantly associated with poorer QOL. Conclusions: Treatment history and expectations and physical comorbidity may affect QOL in HCV-positive patients. Untreated and relapsed patients have comparable levels of QOL and higher scores than NR. Introduction Recent studies have documented impairment in health related quality of life (QOL) in patients with chronic hepatitis C virus (HCV) infection. In particular, HCV patients are reported to complain of fatigue, musculoskeletal pain, right upper abdominal discomfort, depression, mental clouding (brain fog) and perceived inability to function effectively.[1-3] Many studies that compared QOL in patients with compensated HCV infection vs healthy controls without HCV indicated that the former patients have consistently diminished QOL scores across all examined scales.[3,4] In addition, it is well established that HCV patients who achieve a sustained viral response (SVR) after successful therapy have an improved QOL compared with those who failed to respond to the treatment.[5-7] This result has been interpreted as the consequence of eradication of the infection and suggests that the infection itself is the true cause of the reduction of the health related QOL. However, no direct comparison has been performed of the QOL scores of HCV patients who have never been treated with those of patients who did not respond to a previous treatment and of patients who relapsed. All these categories of patients are HCV-RNA positive, nevertheless each of them could have different perceptions of their clinical condition influenced by anxiety regarding diagnosis, prognosis and treatment outcome. The aim of the present study was to evaluate whether HCV-RNA positive patients with recent diagnosis of their HCV infection who have not yet undergone antiviral therapy display significantly different QOL scores compared to patients with long-standing knowledge of HCV infection who underwent antiviral therapy and failed to achieve a viral response [nonresponders (NR)] or relapsed after therapy withdrawal (relapsers). FULL TEXT:http://www.medscape.com/viewarticle/568428?src=mp _________________________________________________________________ Shed those extra pounds with MSN and The Biggest Loser! http://biggestloser.msn.com/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.